Table 1 |
||||
|
Characteristics of the antibodies used |
||||
|
Antibody |
Clone |
Dilution |
Antigen retrieval |
Company |
|
|
||||
|
CK19 |
RCK108 |
1:100 |
HIER EDTA Buffer |
Dako Corp |
|
HBME |
HBME-1 |
1:50 |
HIER EDTA Buffer |
Dako Corp |
|
Galectin 3 |
9C4 |
1:100 |
HIER Citrate Buffer |
Leica Microsystems |
|
Ret Oncoprotein |
3F8 |
1:40 |
HIER EDTA Buffer |
Leica Microsystems |
|
|
||||
|
Dako Corporation, Carpentaria, California Leica Microsystems, Bannockburn, Illinois CK19: cytokeratin 19 |
||||
|
Saleh et al. Diagnostic Pathology 2010 5:9 doi:10.1186/1746-1596-5-9 |
||||
